Editas Medicine, Inc. (EDIT)
2.62
+0.10
(+3.97%)
USD |
NASDAQ |
Oct 02, 16:00
2.60
-0.02
(-0.76%)
After-Hours: 20:00
Editas Medicine Market Cap : 402.25M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 402.25M |
| October 01, 2026 | 386.90M |
| September 30, 2026 | 394.57M |
| September 29, 2026 | 397.64M |
| September 28, 2026 | 385.36M |
| September 25, 2026 | 396.11M |
| September 24, 2026 | 422.21M |
| September 23, 2026 | 413.00M |
| September 22, 2026 | 448.31M |
| September 21, 2026 | 434.49M |
| September 18, 2026 | 414.53M |
| September 17, 2026 | 417.60M |
| September 16, 2026 | 416.07M |
| September 15, 2026 | 403.79M |
| September 14, 2026 | 420.67M |
| September 11, 2026 | 414.53M |
| September 10, 2026 | 406.86M |
| September 09, 2026 | 425.28M |
| September 08, 2026 | 465.20M |
| September 04, 2026 | 495.90M |
| September 03, 2026 | 472.88M |
| September 02, 2026 | 472.88M |
| September 01, 2026 | 471.34M |
| August 31, 2026 | 469.80M |
| August 28, 2026 | 485.16M |
| Date | Value |
|---|---|
| August 27, 2026 | 506.65M |
| August 26, 2026 | 488.23M |
| August 25, 2026 | 503.58M |
| August 24, 2026 | 460.59M |
| August 21, 2026 | 477.48M |
| August 20, 2026 | 451.38M |
| August 19, 2026 | 498.98M |
| August 18, 2026 | 442.17M |
| August 17, 2026 | 436.03M |
| August 14, 2026 | 432.96M |
| August 13, 2026 | 431.42M |
| August 12, 2026 | 436.03M |
| August 11, 2026 | 452.92M |
| August 10, 2026 | 431.42M |
| August 07, 2026 | 442.17M |
| August 06, 2026 | 445.24M |
| August 05, 2026 | 422.21M |
| August 04, 2026 | 425.28M |
| August 03, 2026 | 406.86M |
| July 31, 2026 | 252.50M |
| July 30, 2026 | 263.26M |
| July 29, 2026 | 254.45M |
| July 28, 2026 | 256.41M |
| July 27, 2026 | 262.28M |
| July 24, 2026 | 254.45M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Recursion Pharmaceuticals, Inc. | 2.201B |
| Geron Corp. | 770.96M |
| Halozyme Therapeutics, Inc. | 12.53B |
| Novavax, Inc. | 1.724B |
| AVITA Medical, Inc. | 393.39M |
Market Cap Related Metrics
| PS Ratio | 5.637 |
| Price to Book Value | 3.821 |
| Price | 2.62 |
| Earnings Yield | -28.42% |